News & Events
October 6, 2014
When Science Meets Policy

EuropaBio’s new Guide and Position Paper on Biosimilars in Europe

With these two documents, EuropaBio (European Association of BioIndustries)  continues its contribution to the policy debate on key issues regarding biosimilars among European and national regulators, policy makers, physicians, other healthcare providers and patients.
Both the Guide and the Position Paper stress the need for: distinguishable non-proprietary names for all biological medicines to enhance traceability; transparent information in biosimilar product labels, to facilitate physician and patient understanding as well as respect for physicians’ prescribing authority; and appropriate terms of use in particular for well-treated patients.